Machine learning in healthcare: a guide to use cases and implementation

The scan is read; the claim is paid. The trial runs for two years before anyone flags that half of the enrolled patients don't meet the protocol. In each case, the data that could have caught the problem existed, but it wasn't being used.

That gap is where health systems lose the most in missed diagnoses, fraud paid before it's detected, and drug pipelines that take a decade when they could take two. Machine learning is built to close it. N-iX AI and machine learning services help healthcare and life sciences organizations do exactly that — from data infrastructure through to model deployment and clinical integration.

Here's where ML is already working, what makes it hard, and what it actually takes to get it into production.

Why healthcare organizations are investing in ML now

Machine learning holds around 40% of the AI in healthcare market, ahead of deep learning, NLP, and other technology categories. A 2026 survey of 120 healthcare executives found that 75% are now running at least one AI application, up from 59% the year before, and half of those able to quantify the return reported at least a 2x ROI. More than 80% of healthcare executives believe generative AI and agentic AI will deliver moderate-to-significant value across clinical and business operations in 2026, according to Deloitte Insights. 

The timing isn't accidental. Healthcare organizations are operating under simultaneous pressure from three directions: a workforce shortage that isn't resolving, margin compression that rules out simply hiring more staff, and a volume of digitized patient data from EHRs, imaging systems, wearables, and genomic sequencing that didn't exist at scale a decade ago. ML is the tool that makes that data actionable. The conditions that made it necessary and the infrastructure that made it possible arrived at roughly the same time.

The question most organizations are working through now isn't whether ML has a role. It's which problems to tackle first, what realistic implementation looks like, and how to avoid the failures that have quietly derailed well-funded projects elsewhere.

Top ML use cases in healthcare

According to PwC, the areas with the greatest potential for the use of Machine Learning in healthcare are ML-based medical diagnosis, early identification of potential pandemics, tracking disease incidence, and imaging diagnostics (radiology, pathology). Let’s take a look at these and other use cases in more detail.

Discovering and manufacturing drugs

Finding a viable drug candidate means testing millions of molecular combinations against biological targets, predicting how they'll behave in the human body, and filtering out failures before a single human trial begins. Traditionally, this takes over a decade and costs more than a billion dollars per approved compound, with a clinical trial failure rate above 90%. ML compresses the early stages by predicting protein structures, simulating molecular interactions, and screening out toxic candidates through in silico models rather than lab work.

The practical result is a shorter, cheaper pipeline with better-qualified candidates entering trials. Insilico Medicine brought an AI-designed fibrosis drug candidate into human trials in under 18 months, compared to the four years typical for traditional approaches. Research published in 2024 found that drugs discovered using AI in phase 1 trials have success rates of 80–90%, compared with 40–65% for conventionally discovered compounds.  

For pharmaceutical and biotech organizations, the near-term entry point is usually candidate screening and ADMET prediction,  modeling how a compound will be absorbed, distributed, metabolized, and excreted. The data requirements are well understood, the ROI is measurable within a single pipeline cycle, and it doesn't require replacing existing discovery infrastructure.

Disease identification and diagnosis

Most serious diseases are significantly cheaper to treat and more likely to result in good outcomes when caught early. ML models trained on imaging data, lab results, genomic profiles, and patient histories are built specifically to detect those patterns at a scale and consistency that manual review can't sustain.

The accuracy benchmarks are now strong enough to be clinically meaningful. Harvard Medical School's CHIEF model, validated across 24 hospitals globally, achieved nearly 94% accuracy in detecting 11 cancer types. In cardiology, ML algorithms analyzing ECGs are predicting heart disease before symptoms appear, with classification accuracy reaching 93%.

The implementation question is less about model performance and more about workflow fit. The models that exist today are accurate. The challenge is embedding them in a way that surfaces findings at the right moment without adding friction to an already pressured clinical environment  and that's as much an integration and change-management problem as a technical one.

Better medical imaging

ML models process CT scans, MRIs, X-rays, and pathology slides faster than any human reader and without fatigue. They can simultaneously flag multiple findings across large image sets, early-stage nodules, fractures, and lesions, producing enhanced, reconstructed images with less noise and higher resolution than the raw scan. In low-dose CT specifically, ML can reduce radiation exposure while maintaining image quality, which is important for population-scale screening programs.

The practical value for imaging departments is throughput and consistency. A model doesn't vary in performance across a 12-hour shift or between high-volume Monday mornings and quieter periods. For health systems running mass screening programs for mammography, lung cancer screening, and diabetic retinopathy, consistency directly affects how many early-stage cases are detected and how many are missed.

Fraud detection

According to the Global Healthcare Anti-Fraud Network, approximately $260B is lost to health insurance fraud each year, equivalent to 6% of global healthcare spending. By analyzing vast amounts of data, Machine Learning algorithms can identify patterns and anomalies that may indicate fraudulent activities, thereby saving the industry billions of dollars and ensuring the integrity of healthcare systems.

Similarly, Machine Learning plays a pivotal role in identifying prescription fraud. By analyzing prescription patterns, ML algorithms can flag suspicious activities such as overprescribing, doctor shopping (where a patient visits multiple doctors to obtain more prescriptions), and unusual combinations of medications. For example, if a patient is prescribed multiple opioids by different doctors within a short period, the system can alert authorities to potential abuse or fraud. These insights help healthcare providers and pharmacies ensure that medications are prescribed and dispensed appropriately, thereby protecting patients and reducing the risk of drug abuse.

Read more about generative AI in healthcare

Smarter health records

Clinical documentation is one of the largest sources of inefficiency in healthcare. Physicians spend more time entering data into EHR systems than they do with patients, records are inconsistent across providers and settings, and the unstructured text that makes up the majority of clinical documentation is largely invisible to analytics. The result is a data asset that is simultaneously enormous and underused.

ML addresses this at several levels. Document classification models extract structured information from free text (diagnoses, medications, procedures), making it available for downstream analytics and coding. Optical character recognition handles handwritten or scanned records. Predictive models flag gaps or inconsistencies in a patient's record that suggest missing documentation. The cumulative effect is a record that is more complete, more accurate, and more useful for both clinical decision-making and revenue cycle management.

Smarter clinical trials and research

Getting a new drug through clinical trials takes an average of seven years and costs over $1 billion, with 80% of trials failing to meet enrollment timelines. Most of that delay isn't scientific, but logistical. Finding eligible patients, keeping them enrolled, and processing the data they generate are problems that ML is well-suited to solve.

ML scans EHR databases to match patients against trial criteria across diagnosis codes, lab values, medication history, and demographics, faster and more completely than manual chart review. Models can also score candidates by dropout likelihood based on historical patterns, letting coordinators focus retention efforts before a patient withdraws rather than after. During the trial, continuous ML monitoring flags safety signals and protocol deviations in real time rather than at scheduled review points.

The practical starting point for most organizations is data infrastructure. Trial data is distributed across EHRs, EDC platforms, lab systems, and imaging archives in formats not designed for ML ingestion. Aligning those sources before model development begins determines how quickly everything else moves and is typically where the most time is lost in organizations that start with the model rather than the data.

ML in robotic surgery

Surgical robotics has been in operating rooms for two decades, but the addition of ML is changing what those systems can do, shifting them from tools that execute a surgeon's movements with greater precision to systems that can assist, adapt, and learn from accumulated procedural data. The value lies in making surgical environments more consistent, better informed, and faster to correct when something deviates from expectations.

The integration challenge is significant. Surgical ML operates in a zero-tolerance environment where a false positive is costly and a false negative is dangerous. FDA clearance for AI-assisted surgical guidance is a multi-year process, and regulatory expertise needs to be embedded in the development team from the start, not added at the end.

ML in remote monitoring and wearable devices

Managing a chronic condition between clinical appointments is difficult for patients and operationally invisible for care teams. A patient with heart failure, diabetes, or COPD can deteriorate significantly between a monthly check-in and the next one and the first sign of that deterioration is often an emergency department visit that was preventable. Continuous remote monitoring with ML-based analysis changes this by giving care teams near-real-time visibility into patient status without requiring in-person contact.

ML-powered wearable ECG monitors detect atrial fibrillation with clinical-grade accuracy, catching episodes that a standard clinic ECG will almost always miss because the arrhythmia is intermittent. For heart failure patients, models that monitor weight, blood pressure, and heart rate variability can flag fluid accumulation trends days before the patient develops symptoms severe enough to seek care, catching decompensation in the ambulatory setting rather than in the emergency department, which is better for the patient and significantly cheaper for the health system.

Natural language processing in healthcare

Around 80% of clinical data is unstructured (physician notes, discharge summaries, operative reports, pathology narratives) sitting in free-text EHR fields, invisible to analytics platforms and uncoded for billing. The data exists, it's just inaccessible in its current form. NLP is the layer that extracts structure from it and makes it usable.

The most direct application is coding and the revenue cycle. Conditions a physician documents in a note but doesn't formally code don't appear in the patient's problem list and don't generate appropriate reimbursement under risk-adjusted payment models. NLP-powered coding assistance surfaces these gaps at the point of care rather than in retrospective chart review — recovering revenue that would otherwise be missed and simultaneously improving the accuracy of the clinical record.

Adoption of AI-based clinical documentation grew by 59% year over year between 2025 and 2026, making it the fastest-growing AI application in health systems. For organizations evaluating NLP, the first practical question is EHR access and data governance, and validating model performance on your specific patient population before deployment, not after.

Read more about agentic AI in healthcare

Challenges and limitations of ML in healthcare

ML in healthcare gets a lot of coverage for what it can do. Less attention goes to what makes it difficult, and for decision-makers evaluating whether to invest, the hard parts are exactly what matter.

Data quality and fragmentation

Most healthcare organizations don't have a clean, unified dataset ready for model training. Patient records live across multiple EHR systems, imaging platforms, and claims databases, often in different formats, with inconsistent coding standards and years of incomplete entries. A model is only as good as the data it trains on, and getting that data into usable shape is rarely a one-time job.

At N-iX, data engineering is where most of our healthcare engagements actually start. Before any modeling begins, we assess what data you have, where it lives, and what needs to happen to make it usable. 

Regulatory compliance

An ML model used in clinical decision-making is a medical device under FDA and EU MDR frameworks, which means software validation, audit trails, version control, and in many cases a formal submission process. Organizations that don't plan for this early hit it hard later, when the model is already built.

N-iX builds compliance requirements into the development process from the start. Our teams have worked within HIPAA and GDPR constraints across multiple engagements, and we know what documentation regulators expect. 

Algorithmic bias

A model trained on one patient population doesn't reliably generalize to another. This is one of the most documented failure modes in medical ML,  models that perform well in academic hospital settings but degrade in community clinics, or that show lower accuracy for demographic groups underrepresented in the training data. It often only surfaces when you break results down by subgroup.

We build evaluation frameworks that test performance across relevant demographic and clinical subgroups before anything goes to production. Catching this early costs far less than catching it after deployment.

Explainability and clinician trust

A physician who can't understand why a model flagged a result is unlikely to act on it. Black-box models, however accurate in testing, face real resistance in clinical environments where clinicians are accountable for outcomes.

When we build models for clinical use, we design for interpretability from the start, choosing architectures that allow meaningful explanation and building interfaces that show clinicians the reasoning behind the output, not just the result.

Integration with legacy infrastructure

Most health systems run on EHR platforms and infrastructure that wasn't built with ML in mind. Getting a model into production means connecting it to systems that may be decades old, with limited APIs and strict change control. A model that works in isolation but can't be embedded in clinical workflows delivers no value.

N-iX has experience integrating ML components with major EHR platforms. We build integration layers that work within your existing architecture rather than asking you to replace it.

How N-iX approaches ML in healthcare

After working with healthcare and life sciences organizations across the globe, we've seen the same gap recur: the interest in ML is real, the data exists somewhere, but the path from proof of concept to something that works in a clinical or operational setting is where projects stall. Here's how we approach it.

We start with the decision, not the model. Before any technical work begins, we sit down with your clinical, operational, and IT stakeholders to understand what problem is actually being solved. Which process is slow because someone is manually reviewing data that a model could screen? Which clinical decision is being made without information that already exists in your systems? The answers to those questions determine the architecture, the data requirements, and the success criteria and they prevent the common mistake of building a technically impressive model that nobody uses.

We assess your data before we make promises about it. Healthcare data is rarely clean or consolidated, and a realistic assessment early saves significant pain later. We map what you have, where it lives, what's missing, and what transformation work is needed to make it usable. If the data isn't there yet, we say so  and we can help build the pipeline to get it there.

We build for the clinical environment, not the demo. Production in healthcare means working within EHR workflows, meeting documentation requirements, passing validation, and earning the trust of the clinicians who will actually use the output. We design for all of that from the start explainability, audit trails, error handling, and integration with the systems your teams already use.

We hand over something your team can own. Every model we deploy is documented, monitored, and built so your internal team can understand its behavior, retrain it as data shifts, and maintain it without permanent dependence on us. We treat model governance as part of the deliverable, not an optional add-on.

• N-iX brings together more than 200 ML engineers and data specialists, with delivery experience across healthcare, life sciences and other related industries. 

• We hold relevant certifications: AWS, Azure, GCP  and have worked within HIPAA and EU MDR compliance frameworks across multiple engagements. 

Whether you're evaluating where ML fits in your organization or you have a specific use case ready to build, we work across the full stack:  from data infrastructure to model deployment to clinical integration. For healthcare organizations that already know what they want to improve but haven't found a path to doing it reliably, that's the gap we close.

FAQ 

What is Machine Learning in healthcare?

Machine Learning is a branch of AI where systems learn patterns from data rather than following fixed rules. In healthcare, that means training models on patient records, imaging data, lab results, and claims histories to identify patterns that support clinical decisions, detecting a tumor in a scan, flagging a patient at risk of deterioration, or predicting which drug compound is most likely to succeed in trials. The output is a system that improves with more data, rather than one that has to be manually reprogrammed when conditions change.

How is ML different from AI in healthcare?

AI is the broader category; machine learning is the specific technique that drives most practical healthcare applications today. When a hospital uses AI to read radiology images or predict readmissions, it's almost always an ML model doing the underlying work, trained on historical cases, validated against known outcomes, and deployed to score new patients in real time. Other AI approaches like rule-based systems exist, but ML is what makes modern diagnostic and predictive tools actually useful at scale.

What are the most common uses of ML in healthcare?

The areas seeing the most production deployment right now are medical imaging and diagnostics, clinical documentation, fraud detection in claims processing, drug discovery, and predictive risk scoring for patient deterioration. Administrative automation prior authorization, coding, billing is also growing fast, driven by the direct cost savings it delivers for health systems 

What are the main risks of using ML in healthcare?

The risks decision-makers most commonly underestimate are data quality issues that surface only after model training has begun, algorithmic bias against underrepresented patient populations, regulatory approval timelines for clinical-facing applications, and the difficulty of integrating models into legacy EHR infrastructure. None of these are insurmountable, but each requires planning before the technical work starts not after.

Does ML replace clinicians?

No, and that framing tends to create resistance to adoption that slows down genuinely useful implementations. The role of ML in clinical settings is to handle high-volume, pattern-recognition tasks that consume clinician time without requiring clinical judgment: screening large image sets, flagging anomalies for review, and surfacing relevant patient history before a consultation. Clinicians still make decisions. ML changes what they're spending their time on.